JINSUNG T.E.C., Inc. (KOSDAQ:036890)
South Korea
· Delayed Price · Currency is KRW 14,130
+150 (1.07%)
At close: Mar 6, 2026
JINSUNG T.E.C. Revenue
JINSUNG T.E.C. had revenue of 118.34B KRW in the quarter ending September 30, 2025, with 26.32% growth. This brings the company's revenue in the last twelve months to 431.16B, up 5.98% year-over-year. In the year 2024, JINSUNG T.E.C. had annual revenue of 390.52B, down -19.50%.
Revenue (ttm)
431.16B
Revenue Growth
+5.98%
P/S Ratio
0.61
Revenue / Employee
2.05B
Employees
210
Market Cap
263.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 390.52B | -94.60B | -19.50% |
| Dec 31, 2023 | 485.12B | -55.90B | -10.33% |
| Dec 31, 2022 | 541.01B | 102.69B | 23.43% |
| Dec 31, 2021 | 438.32B | 127.08B | 40.83% |
| Dec 31, 2020 | 311.24B | -44.32B | -12.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kginicis Co.,Ltd | 1,308.46B |
| Bio Solution | 8.27B |
| Cape Industries | 557.74B |
| MNtech | 562.34B |
| Intops | 585.48B |
| CG MedTech | 45.59B |
| Lumir | 9.22B |
| SOS Lab | 4.85B |